AstraZeneca Sells off Seroquel Rights in U.S. and Canada

AstraZeneca Sells off Seroquel Rights in U.S. and Canada

Source: 
BioSpace
snippet: 

AstraZeneca inked a deal with Germany-based Cheplapharm Arzneimittel GmbH to sell the commercial rights to Seroquel and Seroquel XR in the U.S. and Canada. The two drugs are used mostly to treat schizophrenia and bipolar disorder and are no longer under U.S. and Canadian patent protection.